HOME > Chiesi España > Chiesi Spain News
 
Respiration Day 2017
 The present and future of chronic obstructive pulmonary disease is the focus of the Respiration Day 2017: from the new GOLD report to the first extrafine triple combination in a single inhaler,...
1/11
Trimbow® is the first triple combination in a single inhaler for the treatment of COPD to receive positive opinion from the CHMP in Europe
2/11
-
3/11
ARCHIVE NEWS
GLYBERA▼ (ALIPOGENE TIPARVOVEC) IN EUROPE
Chiesi and Molecular Warehouse join forces to create innovative diagnostic tool for transplant patients
Chiesi grants the startup New Born Solutions to participate in the immersion program of Richi Social Entrepreneurs in Boston
Publicado el segundo número de la revista NewsRARE sobre Registros de Pacientes y Medicamentos Huérfanos
-
-
-
-
-
The Lancet publishes the results of Chiesi Farmaceutici TRILOGY study, which shows one year data on the superior efficacy of the first extrafine fixed ICS/LABA/LAMA triple combination for COPD treatment compared with standard therapy
España es uno de los países líderes mundiales en investigación neumológica
FlogoSport ayudando a los deportistas en su rendimiento físico en la carrera “The Mud Day” Sevilla
TicSalut y Chiesi apuestan por modernizar los servicios sanitarios
Los cuidados informales de la EPOC permiten ahorrar hasta 40.000 euros anuales por paciente al sistema sanitario
Beatriz Vila, Directora de Personas de Chiesi ha sido premiada en la categoría de HR Director